NCT02770885View on ClinicalTrials.gov

Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study)

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

May 17, 2019

Study Completion Date

October 7, 2019

Conditions
Primary Polydipsia
Interventions
DRUG

Dulaglutide

Treatment with dulaglutide for 3 weeks.

DRUG

Placebo

Treatment with Sodium Chloride 0.9% (Placebo) for 3 weeks.

Trial Locations (1)

Unknown

University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT02770885 - Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study) | Biotech Hunter | Biotech Hunter